BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 37946533)

  • 1. Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung.
    Kwak G; Lee D; Suk JS
    Expert Opin Drug Deliv; 2023; 20(11):1531-1552. PubMed ID: 37946533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic Acid-Based Therapeutics for Pulmonary Diseases.
    Chen J; Tang Y; Liu Y; Dou Y
    AAPS PharmSciTech; 2018 Nov; 19(8):3670-3680. PubMed ID: 30338490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleic acid therapies for CNS diseases: Pathophysiology, targets, barriers, and delivery strategies.
    Padmakumar S; D'Souza A; Parayath NN; Bleier BS; Amiji MM
    J Control Release; 2022 Dec; 352():121-145. PubMed ID: 36252748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological Barriers and Strategies of Lipid-Based Nanoparticles for Nucleic Acid Drug Delivery.
    Hu M; Li X; You Z; Cai R; Chen C
    Adv Mater; 2024 May; 36(22):e2303266. PubMed ID: 37792475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases.
    Fattal E; Fay F
    Adv Drug Deliv Rev; 2021 Aug; 175():113809. PubMed ID: 34033819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic acid-based therapy for brain cancer: Challenges and strategies.
    Zhang Z; Conniot J; Amorim J; Jin Y; Prasad R; Yan X; Fan K; Conde J
    J Control Release; 2022 Oct; 350():80-92. PubMed ID: 35970297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in modification and delivery of nucleic acid drugs.
    Wang J; Tan M; Wang Y; Liu X; Lin A
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):417-428. PubMed ID: 37643976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular barriers in respiratory gene therapy.
    Sanders N; Rudolph C; Braeckmans K; De Smedt SC; Demeester J
    Adv Drug Deliv Rev; 2009 Feb; 61(2):115-27. PubMed ID: 19146894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid and polymeric carrier-mediated nucleic acid delivery.
    Zhu L; Mahato RI
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1209-26. PubMed ID: 20836625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nucleic acid therapy using multicompartmental delivery systems.
    Attarwala H; Han M; Kim J; Amiji M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Mar; 10(2):. PubMed ID: 28544521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymeric-Micelle-Based Delivery Systems for Nucleic Acids.
    Sinani G; Durgun ME; Cevher E; Özsoy Y
    Pharmaceutics; 2023 Jul; 15(8):. PubMed ID: 37631235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonviral approaches for neuronal delivery of nucleic acids.
    Bergen JM; Park IK; Horner PJ; Pun SH
    Pharm Res; 2008 May; 25(5):983-98. PubMed ID: 17932730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleic acid delivery: the missing pieces of the puzzle?
    Nguyen J; Szoka FC
    Acc Chem Res; 2012 Jul; 45(7):1153-62. PubMed ID: 22428908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase supported design of carriers for therapeutic nucleic acid delivery.
    Krhac Levacic A; Morys S; Wagner E
    Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28963371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advancements in design of nucleic acid nanocarriers for controlled drug delivery.
    Mosley RJ; Rucci B; Byrne ME
    J Mater Chem B; 2023 Mar; 11(10):2078-2094. PubMed ID: 36806872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer.
    Liu Y; Xu CF; Iqbal S; Yang XZ; Wang J
    Adv Drug Deliv Rev; 2017 Jun; 115():98-114. PubMed ID: 28396204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptides for nucleic acid delivery.
    Lehto T; Ezzat K; Wood MJA; El Andaloussi S
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):172-182. PubMed ID: 27349594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticles for vaccine and gene therapy: Overcoming the barriers to nucleic acid delivery.
    Mollé LM; Smyth CH; Yuen D; Johnston APR
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Nov; 14(6):e1809. PubMed ID: 36416028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-viral nucleic acid delivery: key challenges and future directions.
    Elsabahy M; Nazarali A; Foldvari M
    Curr Drug Deliv; 2011 May; 8(3):235-44. PubMed ID: 21291381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of nucleic acids for cancer gene therapy: overcoming extra- and intra-cellular barriers.
    McErlean EM; McCrudden CM; McCarthy HO
    Ther Deliv; 2016 Sep; 7(9):619-37. PubMed ID: 27582234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.